MO vs. PM: Which Tobacco Stock Has More Puff Left in 2025?

Altria (MO) and Philip Morris (PM) present contrasting investment propositions in the evolving tobacco sector. Altria, primarily U.S.-focused, demonstrated Q1 2025 resilience with 10.8% smokeable price gains and 18% growth in 'on!' nicotine pouch shipments, yet faces domestic volume declines and regulatory pressures. In contrast, Philip Morris is strategically positioned for long-term growth with its global smoke-free portfolio, reaching 41.5 million users across 97 markets via IQOS and ZYN, despite recent currency volatility and regulatory scrutiny. While Altria offers income appeal at a 10.96x forward P/E, PM's aggressive global pivot and multi-category approach, reflected in its 20.12x P/E, are deemed to offer superior future growth potential in the industry's transition.

Analysis

Altria Group (MO) and Philip Morris International (PM) are pursuing divergent strategies in the evolving nicotine market. Altria remains a U.S.-centric operation, demonstrating resilience by leveraging strong pricing power in its smokeable segment, which saw a 10.8% net price realization and drove a 2.7% increase in adjusted operating income in Q1 2025. Its primary growth driver is the `on!` oral nicotine pouch brand, with shipments rising 18% and capturing 17.9% of the pouch segment. However, Altria faces significant domestic headwinds, including structural cigarette volume declines, macroeconomic pressures on its core consumer base due to inflation, and regulatory setbacks with its NJOY e-vapor product. In contrast, Philip Morris is executing a global pivot to a smoke-free portfolio, now reaching 41.5 million users across 97 markets. Its growth is propelled by the multi-category success of IQOS, ZYN, and VEEV, reflected in a slightly upwardly revised 2025 EPS estimate of $7.50. While PM is exposed to currency volatility and potential EU regulatory risks, its fundamental growth trajectory appears more robust. This strategic divergence is captured in their valuations: MO trades at a 10.96x forward P/E, characteristic of a value/income stock, while PM commands a 20.12x P/E, reflecting a premium for its international growth prospects and smoke-free leadership, despite its stock's recent 11.6% decline.

Key Decisions for Investors

• Philip Morris appears better positioned for long-term growth due to its successful global execution in smoke-free products and expanding international presence, justifying its premium valuation despite recent stock underperformance.
• Investors considering Altria should weigh its attractive 10.96x P/E and consistent pricing power against significant U.S.-specific risks, including declining cigarette volumes, macroeconomic strain on consumers, and regulatory hurdles for its NJOY brand.
• Monitor near-term catalysts for Philip Morris, such as currency impacts from the Swiss franc and developments regarding the EU Tobacco Excise Directive, as these represent the primary risks to its otherwise strong growth narrative.
• The recent divergence in one-month stock performance, with Altria gaining 2.1% while Philip Morris dropped 11.6%, may present a tactical entry point for investors aligning with PM's superior long-term, smoke-free growth thesis.